Proteomic analysis of left ventricular remodeling in an experimental model of heart failure

Caroline Cieniewski-Bernard1, Paul Mulder, Jean-Paul Henry

  • 1INSERM, U744, Lille, France.

Insights

Chronic heart failure involves left ventricular remodeling. Proteomic analysis reveals altered cardiac metabolism and oxidative stress proteins, offering insights into heart failure mechanisms.

Area of Science:

  • Cardiology
  • Proteomics
  • Molecular Biology

Background:

  • Chronic heart failure (CHF) development post-myocardial infarction involves left ventricular remodeling (LVR).
  • The precise mechanisms driving LVR and global protein alterations remain unclear.
  • Understanding protein pattern changes is crucial for comprehending LVR.

Purpose of the Study:

  • To investigate the global protein expression patterns in the left ventricle during experimental chronic heart failure.
  • To identify specific proteins and pathways affected during left ventricular remodeling.

Main Methods:

  • Differential proteomic analysis of left ventricular proteins in a rat model of myocardial infarction-induced CHF.
  • Two-dimensional gel electrophoresis (2D-gels) and Western blot analysis for protein quantification and validation.
  • Identification of differentially expressed proteins involved in various cellular functions.

Main Results:

  • 49 protein spots were differentially expressed in the left ventricle of CHF rats, identifying 27 distinct proteins.
  • Affected proteins were classified into functional groups including heat shock, endoplasmic reticulum stress, oxidative stress, and metabolic pathways (glycolysis, fatty acid metabolism, TCA cycle, respiratory chain).
  • Proteins related to cardiac metabolism and oxidative stress were significantly modulated during LVR, with distinct stress response pathways in early and late phases.

Conclusions:

  • Cardiac metabolism and oxidative stress proteins are modulated during left ventricular remodeling in chronic heart failure.
  • Specific proteins (glyceraldehyde-3-phosphate dehydrogenase, alphaB-crystallin, peroxiredoxin 2, isocitrate dehydrogenase) correlate with heart failure severity.
  • These findings provide insights into the molecular mechanisms of LVR and potential therapeutic targets.